Exact Mass: 245.10299400000002

Exact Mass Matches: 245.10299400000002

Found 500 metabolites which its exact mass value is equals to given mass value 245.10299400000002, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Debromohymenialdisine

(Z)-Debromohymenialdisine

C11H11N5O2 (245.0912706)

Haplopine

4,8-Dimethoxyfuro[2,3-b]quinolin-7-ol; 7-Hydroxy-8-methoxydictamnine

C13H11NO4 (245.0688046)

Haplopine is an oxacycle, an organonitrogen heterocyclic compound and an organic heterotricyclic compound. Haplopine is a natural product found in Haplophyllum bucharicum, Haplophyllum cappadocicum, and other organisms with data available.

Proglinazine

N-[4-Chloro-6-(isopropylamino)-1,3,5-triazin-2-yl]glycine

C8H12ClN5O2 (245.06794820000002)

5-Deoxy-5-fluorocytidine

C9H12FN3O4 (245.0811804)

Glutaminylvaline

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-methylbutanoate

C10H19N3O4 (245.13754939999998)

Glutaminylvaline is a dipeptide composed of glutamine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Asparaginylisoleucine

(2S,3S)-2-{[(2S)-2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-methylpentanoate

C10H19N3O4 (245.13754939999998)

Asparaginylisoleucine is a dipeptide composed of asparagine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Valylglutamine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoic acid

C10H19N3O4 (245.13754939999998)

Valylglutamine is a dipeptide composed of valine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Isoleucyl-Asparagine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.13754939999998)

Isoleucyl-Asparagine is a dipeptide composed of isoleucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Asparaginylhydroxyproline

(2S,4R)-1-[(2S)-2-Amino-3-(C-hydroxycarbonimidoyl)propanoyl]-4-hydroxypyrrolidine-2-carboxylate

C9H15N3O5 (245.10116599999998)

Asparaginylhydroxyproline is a dipeptide composed of asparagine and hydroxyproline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Asparaginyl-Leucine

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-4-methylpentanoate

C10H19N3O4 (245.13754939999998)

Asparaginyl-Leucine is a dipeptide composed of asparagine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Hydroxyprolyl-Asparagine

2-{[hydroxy(4-hydroxypyrrolidin-2-yl)methylidene]amino}-3-(C-hydroxycarbonimidoyl)propanoate

C9H15N3O5 (245.10116599999998)

Hydroxyprolyl-Asparagine is a dipeptide composed of hydroxyproline and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Leucyl-Asparagine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.13754939999998)

Leucyl-Asparagine is a dipeptide composed of leucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Valyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-methylbutanoyl)-C-hydroxycarbonimidoyl]butanoate

C10H19N3O4 (245.13754939999998)

Valyl-Gamma-glutamate is a dipeptide composed of valine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

N-Phenylacetyl pyroglutamic acid

(5S)-5-acetyl-1-(2-phenylacetyl)pyrrolidin-2-one